Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Taiwan, France, Austria launch Indigenous Tao music archive project
07/30/2025 09:48 PM - Cross-Strait
Taiwan decries Chinese coast guard 'harassment' off Kinmen
07/30/2025 09:35 PM - Society
Supreme Court upholds life sentence for man guilty of double homicide
07/30/2025 09:16 PM - Culture
Taiwan brings jazz and dance to George Town Festival
07/30/2025 08:49 PM - Culture
Taiwan National Railway Museum to open after nine years of restoration work
07/30/2025 08:37 PM